PrefaceCell free DNA (cfDNA) is becoming increasingly prominent as a novel molecular marker for disease prediction and tumor prevention. However, there are still many obstacles before achieving its widespread clinical application, mainly the lack of standards related to cfDNA, resulting in the lack